Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

642
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
642
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

719
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
719

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart failure with mildly reduced ejection fraction (HFmrEF): where are we now?

Heart failure reviews·2026
Same author

Precision Medicine for Anticoagulation Strategies in the Cath Lab: Part 1.

Current cardiology reports·2026
Same author

Clinical Updates in Pulmonary Hypertension.

Reviews in cardiovascular medicine·2026
Same author

Current Advances and Navigating the Complexities of SVG-PCI.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

The High Road Is Clear: Reassuring Evidence for Aortic Valve Safety During Aortic Cusp Ablation.

JACC. Clinical electrophysiology·2026
Same author

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026

Related Experiment Video

Updated: Dec 7, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.8K

Machine learning prediction in cardiovascular diseases: a meta-analysis.

Chayakrit Krittanawong1,2, Hafeez Ul Hassan Virk3, Sripal Bangalore4

  • 1Section of Cardiology, Baylor College of Medicine, Houston, TX, USA. Chayakrit.Krittanawong@bcm.edu.

Scientific Reports
|September 30, 2020
PubMed
Summary

Machine learning algorithms show promise for predicting cardiovascular diseases like heart failure and stroke. Boosting and Support Vector Machine (SVM) algorithms demonstrate strong predictive abilities, aiding clinical data interpretation.

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Related Experiment Videos

Last Updated: Dec 7, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Machine learning (ML) algorithms are increasingly used for cardiovascular disease (CVD) prediction.
  • Assessing the overall predictive performance of various ML algorithms is crucial for clinical application.

Purpose of the Study:

  • To systematically evaluate and summarize the predictive capabilities of ML algorithms for major cardiovascular diseases.
  • To identify the most effective ML algorithms for conditions including coronary artery disease, heart failure, stroke, and cardiac arrhythmias.

Main Methods:

  • A comprehensive literature search was conducted across MEDLINE, Embase, and Scopus databases up to March 15, 2019.
  • Included 103 cohorts totaling 3,377,318 individuals to assess ML algorithm predictive ability.
  • Meta-analysis was used to pool performance metrics, primarily the area under the curve (AUC).

Main Results:

  • For coronary artery disease prediction, boosting algorithms achieved a pooled AUC of 0.88, while custom-built algorithms reached 0.93.
  • For stroke prediction, Support Vector Machine (SVM) algorithms showed a pooled AUC of 0.92, followed by boosting (0.91) and Convolutional Neural Network (CNN) (0.90).
  • While limited data existed for heart failure and cardiac arrhythmias, SVM algorithms may offer superior performance.

Conclusions:

  • ML algorithms, particularly SVM and boosting, exhibit promising predictive performance for cardiovascular diseases.
  • Heterogeneity exists among ML algorithms, necessitating careful consideration for specific datasets.
  • Findings can guide clinicians in selecting and interpreting ML models for improved cardiovascular risk prediction.